These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 17764959)

  • 1. Substrate specificity of prostate-specific membrane antigen.
    Anderson MO; Wu LY; Santiago NM; Moser JM; Rowley JA; Bolstad ES; Berkman CE
    Bioorg Med Chem; 2007 Nov; 15(21):6678-86. PubMed ID: 17764959
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Crystal structure of prostate-specific membrane antigen, a tumor marker and peptidase.
    Davis MI; Bennett MJ; Thomas LM; Bjorkman PJ
    Proc Natl Acad Sci U S A; 2005 Apr; 102(17):5981-6. PubMed ID: 15837926
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Structural basis of interactions between human glutamate carboxypeptidase II and its substrate analogs.
    Barinka C; Hlouchova K; Rovenska M; Majer P; Dauter M; Hin N; Ko YS; Tsukamoto T; Slusher BS; Konvalinka J; Lubkowski J
    J Mol Biol; 2008 Mar; 376(5):1438-50. PubMed ID: 18234225
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The molecular pruning of a phosphoramidate peptidomimetic inhibitor of prostate-specific membrane antigen.
    Wu LY; Anderson MO; Toriyabe Y; Maung J; Campbell TY; Tajon C; Kazak M; Moser J; Berkman CE
    Bioorg Med Chem; 2007 Dec; 15(23):7434-43. PubMed ID: 17869524
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Structural characterization of P1'-diversified urea-based inhibitors of glutamate carboxypeptidase II.
    Pavlicek J; Ptacek J; Cerny J; Byun Y; Skultetyova L; Pomper MG; Lubkowski J; Barinka C
    Bioorg Med Chem Lett; 2014 May; 24(10):2340-5. PubMed ID: 24731280
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Reaction mechanism of glutamate carboxypeptidase II revealed by mutagenesis, X-ray crystallography, and computational methods.
    Klusák V; Barinka C; Plechanovová A; Mlcochová P; Konvalinka J; Rulísek L; Lubkowski J
    Biochemistry; 2009 May; 48(19):4126-38. PubMed ID: 19301871
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A Novel ¹¹¹In-Labeled Anti-Prostate-Specific Membrane Antigen Nanobody for Targeted SPECT/CT Imaging of Prostate Cancer.
    Chatalic KL; Veldhoven-Zweistra J; Bolkestein M; Hoeben S; Koning GA; Boerman OC; de Jong M; van Weerden WM
    J Nucl Med; 2015 Jul; 56(7):1094-9. PubMed ID: 25977460
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prostate-specific membrane antigen (PSMA)-mediated laminin proteolysis generates a pro-angiogenic peptide.
    Conway RE; Rojas C; Alt J; Nováková Z; Richardson SM; Rodrick TC; Fuentes JL; Richardson NH; Attalla J; Stewart S; Fahmy B; Barinka C; Ghosh M; Shapiro LH; Slusher BS
    Angiogenesis; 2016 Oct; 19(4):487-500. PubMed ID: 27387982
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparison of human glutamate carboxypeptidases II and III reveals their divergent substrate specificities.
    Navrátil M; Tykvart J; Schimer J; Pachl P; Navrátil V; Rokob TA; Hlouchová K; Rulíšek L; Konvalinka J
    FEBS J; 2016 Jul; 283(13):2528-45. PubMed ID: 27208881
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Selection and characterization of Anticalins targeting human prostate-specific membrane antigen (PSMA).
    Barinka C; Ptacek J; Richter A; Novakova Z; Morath V; Skerra A
    Protein Eng Des Sel; 2016 Mar; 29(3):105-15. PubMed ID: 26802163
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mapping of the active site of glutamate carboxypeptidase II by site-directed mutagenesis.
    Mlcochová P; Plechanovová A; Barinka C; Mahadevan D; Saldanha JW; Rulísek L; Konvalinka J
    FEBS J; 2007 Sep; 274(18):4731-41. PubMed ID: 17714508
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Phosphoramidate derivatives of hydroxysteroids as inhibitors of prostate-specific membrane antigen.
    Wu LY; Do JC; Kazak M; Page H; Toriyabe Y; Anderson MO; Berkman CE
    Bioorg Med Chem Lett; 2008 Jan; 18(1):281-4. PubMed ID: 18023582
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prospective Comparison of 18F-Fluoromethylcholine Versus 68Ga-PSMA PET/CT in Prostate Cancer Patients Who Have Rising PSA After Curative Treatment and Are Being Considered for Targeted Therapy.
    Morigi JJ; Stricker PD; van Leeuwen PJ; Tang R; Ho B; Nguyen Q; Hruby G; Fogarty G; Jagavkar R; Kneebone A; Hickey A; Fanti S; Tarlinton L; Emmett L
    J Nucl Med; 2015 Aug; 56(8):1185-90. PubMed ID: 26112024
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The homodimer of prostate-specific membrane antigen is a functional target for cancer therapy.
    Schülke N; Varlamova OA; Donovan GP; Ma D; Gardner JP; Morrissey DM; Arrigale RR; Zhan C; Chodera AJ; Surowitz KG; Maddon PJ; Heston WD; Olson WC
    Proc Natl Acad Sci U S A; 2003 Oct; 100(22):12590-5. PubMed ID: 14583590
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Identification of MHC class II-restricted T-cell epitopes in prostate-specific membrane antigen.
    Schroers R; Shen L; Rollins L; Xiao Z; Sonderstrup G; Slawin K; Huang XF; Chen SY
    Clin Cancer Res; 2003 Aug; 9(9):3260-71. PubMed ID: 12960111
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Preparation of asymmetric urea derivatives that target prostate-specific membrane antigen for SPECT imaging.
    Harada N; Kimura H; Ono M; Saji H
    J Med Chem; 2013 Oct; 56(20):7890-901. PubMed ID: 24063417
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prostate-specific membrane antigen as a target for cancer imaging and therapy.
    Kiess AP; Banerjee SR; Mease RC; Rowe SP; Rao A; Foss CA; Chen Y; Yang X; Cho SY; Nimmagadda S; Pomper MG
    Q J Nucl Med Mol Imaging; 2015 Sep; 59(3):241-68. PubMed ID: 26213140
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Anti-prostate-specific membrane antigen liposomes loaded with 225Ac for potential targeted antivascular α-particle therapy of cancer.
    Bandekar A; Zhu C; Jindal R; Bruchertseifer F; Morgenstern A; Sofou S
    J Nucl Med; 2014 Jan; 55(1):107-14. PubMed ID: 24337602
    [TBL] [Abstract][Full Text] [Related]  

  • 19. DNA fusion gene vaccines induce cytotoxic T-cell attack on naturally processed peptides of human prostate-specific membrane antigen.
    Vittes GE; Harden EL; Ottensmeier CH; Rice J; Stevenson FK
    Eur J Immunol; 2011 Aug; 41(8):2447-56. PubMed ID: 21604260
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Human glutamate carboxypeptidase II inhibition: structures of GCPII in complex with two potent inhibitors, quisqualate and 2-PMPA.
    Mesters JR; Henning K; Hilgenfeld R
    Acta Crystallogr D Biol Crystallogr; 2007 Apr; 63(Pt 4):508-13. PubMed ID: 17372356
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.